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After reviewing how psychological treatment for chronic pain comes to have its 
current form, and summarizing treatment effectiveness, we explore several areas of 
development. We describe third wave therapies, such as mindfulness; we discuss 
what the research literature aggregated can tell us about what trials are more useful to 
conduct; and we outline some areas of promise and some failures to deliver on promise. 
The article is drawn together using the framework of the normal psychology of pain, 
identifying some of its most important implications for improving life for people with 
chronic pain.
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Nouveaux développements de la prise en charge psychologique  
de la douleur chronique
Après avoir étudié comment le traitement psychologique de la douleur chronique en est 
venu à sa forme actuelle, et résumé l’efficacité des traitements, nous explorons plusieurs 
domaines du développement. Nous décrivons les thérapies de troisième vague comme 
la pleine conscience, nous discutons de ce que peut nous apprendre la littérature de 
recherche regroupée à propos des essais les plus utiles à mener, nous présentons 
des domaines prometteurs et d’autres qui n’ont pas tenu leur promesse. La structure 
de l’article est le cadre de la psychologie normale de la douleur, qui identifie certaines 
des implications les plus importantes pour améliorer la vie des personnes souffrant de 
douleur chronique.
Psychological treatments for chronic pain have been in continuous development since the 1960s, broadly 
parallel to changes in mainstream psychological treatments, 
especially within the ambit of CBT. There are several 
conceptual threads that can be discerned in the current state.1
Behavioural
Behavioural methods apply operant learning theory to the 
analysis of pain. The primary objective is to modify a range 
of pain-related behaviours, such as activity, medication 
use, and social interactions, by changing environmental 
contingencies and the settings in which pain-related 
behaviour occurs. The cardinal feature of the original 
behavioural approach was that it explicitly eschewed direct 
attempts to modify the sensory-intensity component of the 
pain experience.2
Cognitive
Cognitive components were added to treatment protocols 
during the 1970s, starting with the application of 
Meichenbaum’s stress inoculation training (see Turk et al3), 
where the focus was on teaching people with pain to 
modify their responses to it by changing their appraisal 
and response options through self-instruction. Perhaps 
the most systematic application of this approach has been 
Keefe’s Coping Skills Training protocol (see Keefe et al4), 
incorporating aspects of Fordyce’s behavioural model5 and 
insights from Beck’s cognitive therapy (see Beck et al6); 
detection of automatic thoughts, classification of thinking 
(overgeneralizing), and behavioural experiments to test 
specific predictions about the relation between thoughts, 
behaviour, and pain.7 By 2000, it was clear that there 
was no single definitive cognitive-behavioural protocol, 
and treatment programs usually comprised multiple 
components (Table 1). Nevertheless, behavioural methods 
continue to develop, notably a highly specific form of 
graded exposure in vivo to threatening pain-related 
movements. This treatment was developed by Vlaeyen 
(see Vlaeyen et al8) following initial work by Philips9,10 
and others. It is derived from learning theory to treat pain-
related behaviour that is governed by fear and avoidance 
contingencies.
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Abbreviations
ACT acceptance and commitment therapy
CBT cognitive-behavioural therapy
ES effect size
TAU treatment as usual
Highlights
• Psychological treatments for chronic pain are well 
established and there is good evidence for their 
effectiveness, but there are significant challenges to be 
met if the field of psychological treatment for chronic 
pain is to advance.
• These challenges include the following: enhancing the 
overall magnitude of the treatment effect; identifying 
the effects of the different components of the complex 
intervention by studying them individually; improving 
measurement; and developing agreed on clinically 
appropriate criteria for assessing therapeutic gain.
• Implementing treatment using rapidly developing 
information technology remains promising but robust 
evidence of its clinical utility is not yet available.
• After 50 years of treatment development, we suggest 
that reconsideration and reconceptualizing of a 
psychology of chronic pain that highlights normal 
processes would be beneficial.
Third Wave Treatments
In addition to the 2 main strands in CBT, psychologists 
working in chronic pain have developed what have 
become collectively known as third wave treatments, the 
wave referring to the philosophy of the treatment. The 2 
developments most researched in chronic pain are ACT and 
mindfulness.11 ACT is rooted in a radical-behaviourist analysis 
of the function of language and supported by psychological 
science. By contrast, mindfulness is based in millennia of 
Buddhist practice. It was initially used to treat chronic pain 
by Kabat-Zinn in the 1980s12 but was only disseminated later 
after its introduction in adult mental health,13 particularly 
depression. In addition, the application of related traditional 
medicine methods, such as Qigong,14 yoga,15 and variants of 
mindfulness,16 have been provided with rationales reworked 
to map onto contemporary psychological thinking.
Summary
Although one can find examples of stand-alone treatments, 
such as graded exposure, most treatment protocols blend 
several CBT components. While the intention may be to 
boost the active ingredients in treatment, the truth is that we 
have little evidence to support the merits of one combination 
of components over another. Thus it is not uncommon to 
find a clinical program with multiple components: pacing 
(operant), graded exercise, mindfulness meditation, and 
coping skills. As a consequence, there are many complex 
interventions, but the inclusion of particular components is 
not always well explained, thus we have no standardized 
and agreed protocols.
Evidence of Effectiveness
There are several meta-analyses of psychological interventions 
for chronic pain.17–27 They reveal that CBT has a beneficial 
effect for the average patient, on a broad range of outcomes. 
Table 2 lists the outcome domains typically used. In the first 
substantive meta-analysis,22 CBT was more effective than no-
treatment or TAU, with a median Cohen d ES of around 0.5. 
In later analyses, CBT remained superior to no-treatment or 
TAU, but the magnitude of d was diminished to around 0.2,23 
similar to the estimates obtained in other meta-analyses for 
mixed chronic pain, low back pain,21 fibromyalgia,19,24,28,29 and 
arthritis.30 While these data are encouraging, it is salutary to 
note that a between-group Cohen d ES of 0.2 means that the 
average person in the treated group is at the 58th percentile 
of the untreated group, or the 69th percentile when the ES 
equals 0.5. As most trials report statistical rather than clinical 
significance, estimating the true clinical effectiveness of 
treatment in a user-friendly manner is problematic.
Why does it appear that treatments have become less 
effective in the last 40 years? There is no single reason, but 
we offer some explanations as to why the research data have 
led to this conclusion. More rigorous meta-analyses either 
remove or appropriately weight trials that are likely to be 
biased. For example, early trials, with very small samples, 
may be excluded a priori from analysis or their influence 
diminished by many larger, appropriately powered trials. 
There is also evidence that more recently designed trials 
are of better quality. Scales for assessing design quality 
of complex interventions that cannot be double blind31 
indicate an improvement in controlling various biases, 
such as blinding of assessors, better randomization, better 
data analysis protocols, and equivalence of treatment 
expectations.
In a recent revision of a meta-analysis (see Williams et al23) 
and a subsequent review (see Morley et al32), we raised 
concern that the apparent reduction in the effectiveness 
of CBT treatments may also be influenced by reduction 
in both the amount of treatment given and the skill level 
of therapists. Pressure on service delivery is such that 
the driving force to disseminate an apparently effective 
treatment has been greater than our knowledge of the 
factors that determine the effective delivery. Although it is 
clear that there are differences between therapists in their 
effectiveness,33 as Ehde et al34 note, “The degree to which 
the training, experience and interpersonal qualities of the 
CBT interventionist, affect CBT outcomes is unclear.”p  159
Related to the issue of therapist competence is the real 
possibility that many current implementations of CBT may 
be relatively weak. As noted earlier, there is significant 
variation in the content, duration, and format of treatments 
delivered under the rubric of CBT, and many authors 
provide only brief details of interventions. This situation is 
in marked contrast to the early behavioural model in which 
specific interventions were designed to obtain specific 
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Table 1  Some of the components of cognitive 
behavioural treatment of chronic pain
Education
Teaching about pain and the importance of psychological 
and behavioural factors is essential as part of a program’s 
strategy to engage patients.
Goal setting 
This may encompass targeting particular areas for 
all patients, for example, work or domestic duties, to 
individualized and iterative goal setting.
Relaxation and (or) biofeedback 
These may be taught using a single technique, such as 
diaphragmatic breathing or progressive muscular relaxation 
or a set of different techniques to be applied across different 
settings.
Graded activity, exercise and fitness training, and activity 
pacing 
This may range from written or verbal advice on posture, 
body mechanics, ergonomics, and recommended exercise 
routines through to specific exercises and techniques 
targeted at movement and exercise integrated with the 
patient’s physical strength and deficits and with their 
personal goals.
Operant principles
This requires a detailed functional analysis of the problem 
to identify the antecedents, for example, presence of 
others, type of social interaction, and place, where the 
behaviour is most likely to occur, and the identification of 
likely reinforcers.
Behavioural experiments
These are an integral part of mainstream cognitive 
therapy and the main vehicle for producing cognitive 
and behavioural change. Behavioural experiments 
are developed to test an individual’s beliefs about the 
consequences (emotional, behavioural, and cognitive) of 
either engaging or not engaging in particular behaviours.
Attention management
At the simplest level this consists of provision of advice 
on one or more methods, such as the use of distraction or 
imagery control techniques. Experiential methods should be 
used to teach the techniques.
Cognitive restructuring
This includes various methods aimed at changing both 
content and process of thinking.
Problem solving 
This involves identification of the problem, generation of 
a range of possible solutions, prioritizing among those 
solutions according to opportunities, resources, and risks, 
and then attempting them.
Generalization and maintenance strategies
A thorough program will pay attention to generalizing 
treatment gains and developing maintenance strategies.
behavioural outcomes: increasing activity; increasing 
well behaviour, such as return to work; and decreasing 
health care use.2 This allowed researchers to specify and 
measure, with some precision, both the intervention and 
behavioural changes that should be observed as treatment 
is implemented; the link between treatment process 
and outcome was under constant scrutiny. The same 
precision is also observed in graded exposure treatment 
derived from the fear-avoidance model.8 The conduct of 
behavioural experiments lies at the heart of effective CBT, 
and at the centre of this approach is a careful analysis 
of the individual and specific interventions designed to 
modify particular cognitive appraisals, behaviour, and 
emotional responses. Does the contemporary treatment of 
chronic pain follow this protocol? Changing behaviour is 
difficult, especially when it involves increased pain, albeit 
for a limited period. We suggest that more attention should 
be given to documenting effects of various components35 
that comprise CBT rather than simply adding components 
to existing packages.
Finally, might measurement imprecision and methodology 
mislead us on the effectiveness of treatments for chronic 
pain? Paradoxically using highly reliable well-developed 
scales (sometimes developed for other purposes, for example, 
Short Form-36) may limit sensitivity to detect changes. In 
scale development, items are excluded on psychometric 
grounds rather than relevance, thus an individual is scaled 
with reference to the inherent variability in the scale, not 
by performance in their unique behavioural world. While 
this allows us to measure differences in common items, it is 
insensitive to difference in meaningful behaviour within an 
individual across settings and (or) time; both are important 
in evaluating treatment. For the most part, scales do not 
sample the function of the behaviour or the context in which 
it occurs or its effectiveness in relation to goals. Most often, 
items sample frequency of the behaviour in relative terms, 
sacrificing precision for psychometric gain.
The second issue in evaluating treatment effectiveness is 
the nature of the criterion used for success. Most scales 
used in trials and in clinical settings are continuously 
distributed; change is evaluated by mean differences, whose 
significance is judged by statistical criteria, a P value or 
an ES, dependent on sample parameters (for example, n, 
variance, and mean difference). There is nothing inherent 
in this approach that relates the evaluation to meaningful 
clinical criteria.36 Clinical criteria can be derived from 
continuous measures37,38 but are rarely used in studies of 
psychological treatments for chronic pain.32 Thus we still do 
not know what proportion of people will make a meaningful 
clinical gain as a result of treatment, only that some will.
In summary, there are 2 significant challenges for future 
research: first, to improve the overall magnitude of treatment 
gain, and, second, to develop an agreed measurement 
protocol that is based on clinical and not just statistical 
criteria. The work of the IMMPACT (Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials)39 
group has made significant progress in this area.
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Table 2  Outcome domains and sample measures used in randomized controlled trials 
Domain Sample measures
Coping and cognitive appraisal Cognitive strategies and appraisals used to manage pain; Coping Strategies Questionnaire;  
general and specific self-efficacy or catastrophizing scales; Chronic Pain Acceptance Questionnaire
Disability Activities of daily living; impact on health and lifestyle; Arthritis Impact Measurement Scale; 
Oswestry Disability Index; Sickness Impact Profile; activities of daily living and physical disability 
subscales
Mood Depression, anxiety, and other states; Hospital Anxiety and Depression Scale; Beck Anxiety 
Inventory; Beck Depression; anger scales
Pain behaviour or activity Behavioural acts associated with pain, including walking distance; Pain Behaviour checklist; 
direct observation of pain behaviours; number of medications and visits to health care professionals
Pain experience Ratings of pain intensity, sensation, and unpleasantness; Brief Pain Inventory; relevant subscales 
of McGill Pain Rating Index; numerical, verbal, or visual analogue pain rating scales
Physiology or fitness Assessments of biological functioning and physical fitness
Social role functioning Assessments of the ability of the person to function in various social roles, including familial, leisure, 
and employment
What Drives the Development of Treatment?
Historically, psychological treatments have been delivered 
primarily in specialist care to a highly disabled subsample 
of patients. Over the years, forms of treatment have 
been disseminated to primary care and to occupational 
environments; incorporated into treatments based in other 
disciplines (for example, physiotherapy40,41); and applied 
as a secondary prevention strategy.42 What has driven 
the proliferation of treatments and what does it signify? 
Disregarding therapist whim and fashions in therapy, 
answering these questions may help us direct research in the 
future. Is it that each new development has incrementally 
improved the effectiveness of treatment or engaged a 
section of the treatment population previously untouched by 
treatment? That is certainly a commonly expressed belief. 
Has the change in treatment content meant that more patient 
groups can be helped? The pessimistic answer to these 
questions is, probably not. The preceding précis of meta-
analysis suggests that there is little evidence of incremental 
improvement in efficacy, quite the reverse. The drive to make 
treatment briefer, cheaper, and better is likely to founder on at 
least one of these aims in achieving the others.
Our guess is that future trials will be driven by 2 main 
features. First, funders, often branches of government 
responsible for health services research, will commission 
new trials to test the efficacy of CBT or other treatments 
in various forms, for a range of disorders. This thinking is 
grounded in the model of testing drug therapies and is wedded 
to the dominance of a diagnostic framework essentially 
based on biological characteristics of the phenomenon: 
location, pain characteristics, presumed cause (nociceptive, 
compared with neurogenic), risk factors, and comorbidities. 
This is apparent in various proposals for classifying pain 
conditions.43–45 We suspect that we will continue to see trials 
of specific protocols, delivery formats, diagnostic groups, 
and outcomes. If we express this as a general question, Are 
treatment protocols X, Y, and Z effective for disorders A, 
B, and C for outcomes P, Q, R, and S?—it is apparent that 
there are many combinations of Treatment × Disorder × 
Outcome. This approach is facilitated by the sophisticated 
plug-in-and-play health services research methodology in 
which large trials of high-quality and sophisticated analyses 
are performed. Considering the need for replication, the 
evolving and changing nature of diagnosis and the poor 
previous track record of demonstrating superiority of a 
treatment when pitched against a genuine well-matched 
comparator, this strategy is financially unsustainable, 
irrespective of its debatable scientific rationale. This 
position is analogous to an analysis of psychotherapy 
research some 25 years ago.46 Nevertheless, we suspect that 
the funding ecosystem will sustain the present strategy of 
clinical research for the foreseeable future. Undoubtedly, 
patients will benefit from it. The questions are as follows: 
Will enough of them gain adequate benefit? And, could 
those funds be spent to greater benefit? We suspect that the 
answer to the latter question is, probably, yes.
The second impetus for further trials is that no therapeutic 
modality yet has had a definitive answer for chronic pain and 
the limitations of our current psychological (see comments, 
supra) and pharmacological approaches are evident.47 Quite 
understandably, people remain open to new treatments and 
treatment variations that promise the reduction or elimination 
of pain or address the distress associated with chronic pain, 
for example, the applications of Qigong14 and loving-kindness 
meditation.16 Such interventions are often driven by enthusiasts 
and represented by small trials from which it is hard to 
generalize with any confidence. In response to suffering, 
patients and therapists will continue to look for solutions.
Self-Management
Resources to help and support people with chronic pain fall 
several orders of magnitude short of the numbers of people 
with chronic pain. This has led to both honest and opportunist 
use of self-management terminology to persuade funders to 
invest in programs designed to enable patients to become 
more independent in managing their pain and, in particular, 
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to draw less on health service resources. Nevertheless, 
the self-management offered incorporates everything 
from extensive CBT or other therapeutic interventions as 
described above, to supportive patient-led groups with 
minimal evidence that they improve function or even 
mood; there are many varieties in between. Ideally, self-
management is effectively an outcome of any successful 
treatment, whether surgical, pharmacotherapeutic, or 
rehabilitative. It may be conceptualized as incorporating
1) personalized explanation of pain and prognosis, so that 
the patient better understands what pain does and does 
not mean;
2) a plan for dealing with exacerbations of pain and 
knowing when to re-consult;
3) a plan for return towards more normal or desired 
activities by gradual, steady increments;
4) when appropriate, plans to bolster current support 
networks at home, work, or elsewhere; and
5) plans for analgesic maintenance or reduction.
The aim should be to improve pain experience where 
possible, but with quality of life—incorporating distress and 
disability—as the major outcome. It is clear that interventions 
that fall short of this are unlikely to offer patients much, and 
most unlikely to reduce health care use.
Likely Developments and Challenges
CBT is, for the most part, the de facto treatment framework 
for a wide range of disorders the most extensively researched 
in recent decades. There is no reason why it cannot be 
effectively applied to a wide variety of populations. The 
changes that occur in chronic pain to the entire central 
nervous system and brain do not differentiate in any way 
between, for instance, the individual with diagnosed 
osteoarthritis or the individual with joint pain but no X-ray 
findings, nor between the individual with celiac disease 
and another with irritable bowel syndrome.48 Although 
much research and clinical effort have focused on adults 
of working age with chronic pain, CBT has been applied 
to help children18,49 and older adults,50 and to those with 
pain at the end of life.51–54 We suspect that clinicians and 
researchers will continue to apply the general principles of 
CBT to a wide range of pain-related disorders. We suggest 
several specific areas that are particularly challenging.
Personalizing or Tailoring Treatment
There are far fewer attempts to tailor treatment than there are 
published exhortations to do so,55 but evidence for improved 
outcomes is still lacking. Recent trials56,57 are disappointing, 
with significant issues relating to the accurate pretreatment 
profiling required.58 In some trials, individual preference 
was used rather than individual need, but the 2 may not 
correspond.59 As with dismantling trials, unless component–
outcome relations are assumed to be specific and unique, 
which the evidence demonstrates is not so, these studies will 
not enable us to better suit treatment to patients.
Implementing Technology
The development of technology-assisted programs 
includes sophisticated interactive telephone-based 
systems to enhance the generalization of treatment gains 
over time,60,61 Internet-delivered treatment protocols62–64 
(in which the Internet is used to provide the treatment 
material, under supervision, to a preselected targeted 
group), and well-curated websites65 that provide structured 
self-help treatment modules based on CBT. More recently, 
the widespread dissemination of mobile phones with 
efficient Internet connectivity permits the collection of 
clinical data cost-effectively and in real time. Currently, 
such applications do little more than collect, integrate, and 
display data, assuming that the information is useful to 
the individual, clinician, or both, but evidence for clinical 
utility is lacking.66–68 Applications that can simulate 
interaction with a therapist are in development.
Undoubtedly, the next generation of people with chronic 
pain will be much more familiar and comfortable using 
information technology, especially mobile and social media, 
as coaches and sources of help. This raises complex issues 
of how to provide high-quality content that is delivered in a 
timely manner and in a way that engages and motivates and 
supports behavioural change. At present, this appears to be 
merely promissory.
Management of Iatrogenic Problems
The issue of the use of opioids in the management of 
noncancer pain remains a challenge. In Canada, the 
National Opioid Use Guideline Group69,70 has developed 
the Canadian Guideline for Safe and Effective Use of 
Opioids for Chronic Non-Cancer Pain to assist with 
appropriate use of opioids in patients whom physicians 
think may benefit from an opioid trial. Opioids are 
associated with physiological dependence and, in people 
at risk, may also be associated with substance misuse as 
evidenced in rising overdose figures71; this, combined with 
increasing appreciation of long-term risks, particularly 
hyperalgesia and endocrine problems,72,73 means that if 
there is an absence of demonstrable benefit in pain or 
function in a particular patient, they should be encouraged 
to reduce or discontinue the opioid. While this would 
ideally be done with support and supervision, and while 
building alternative skills in pain management,74 many 
treatment programs exclude opioid users, or accept them 
but do not address opioid reduction as a goal.75 That is 
a regrettable gap in provision, as addiction services are 
rarely able to provide the combined drug withdrawal and 
pain management that patients need.76
Trauma-Related Pain
People with chronic pain from military veteran or civilian 
populations may have posttraumatic stress symptoms 
from accidents or assaults. These symptoms may include 
complex patterns of avoidance and distress that need to be 
addressed alongside pain management, but there are few 
published accounts of such work.
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Language and Culture
Face-to-face therapy requires a common language or an 
interpreter; technology-based programs are more easily 
delivered in multiple languages. But problems go beyond 
language, in that cultural norms may conceptualize pain 
entirely as a medical problem to be subjected to specialist 
treatments, while the associated suffering is in the private 
domain, shared only with close family. We need to improve 
our explanations of psychologically informed models of 
pain and pain management, and to increase low rates of 
take-up of services in certain ethnic groups.
Rethinking Pain From a  
Psychological Perspective
Perhaps the biggest challenge is how to conceptualize 
chronic pain in a way that advances the development of 
treatment effectiveness. In contrast with recent attempts 
to systematize by advancing diagnostic classification,45 
we suspect that the development of a psychology of pain 
based on a thorough understanding of a normal process 
would be more beneficial. What Eccleston77 has called 
the normal psychology of pain seeks to understand how 
the experience of pain impacts on normal processes and 
the subsequent range of adaptations people make as a 
result of the challenges that arise. Examples of developing 
this approach is work on attention and memory78–80 
and social interaction.81,82 Morley83 suggested that the 
various processes can be encompassed within 3 broad 
categories: the relatively interruptive consequences of pain 
(attention processes); interference, the impact of pain on 
the behavioural performance of tasks and roles; and the 
challenge that pain presents to maintaining and developing 
personal and social identity.84
This approach focuses on understanding process rather 
than the aggregation of symptoms into diagnostic 
descriptive categories. Therefore, it identifies the anxiety 
and distress associated with pain not as comorbidities but 
common outcomes of worry, frustration, losses of roles 
and pleasures, and fears about the future. The project 
of developing a normal psychology of pain has various 
implications of relevance here. One is that distress and 
psychological disturbance is understood first in the 
context of the meaning of pain for the individual, not 
in psychiatric or characterological terms. It alerts us to 
the role of the researcher or clinician as observer, and 
to his or her moral and cultural biases (for example, see 
Encandela85). It is entirely consistent with the rapidly 
expanding field of neuroscience, in which excitatory pain 
pathways become active, and inhibitory pathways are 
quiet, in the presence of anxiety,86 depression,87 threat,88 
and catastrophic thoughts about pain,89 and the opposite 
happens as people with pain learn to regain control by 
various methods, such as CBT or mindfulness.90 This 
opens up the possibility that, in future, rather than aiming 
to use psychological methods only to rehabilitate people 
despite ongoing pain, we will start to target their pain as 
well.
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